Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 4 Interventional

Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment

ClinicalTrials.gov ID: NCT06367387

Public ClinicalTrials.gov record NCT06367387. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Aug 29, 2026, 4:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pain Self-Management and Patient-Oriented Dosing for Pain and Retention in Office-based Addiction Treatment: a Randomized Trial

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study seeks to improve the treatment of chronic pain in people who are taking buprenorphine (also known as Suboxone, Subutex, Zubsolv). The research study is testing two different interventions along with usual clinical care: 1. Pain Self-Management (PSM): an educational program in which individuals with chronic pain work with a trained pain coach and a pain peer to explore strategies to effectively manage the daily problems that arise from chronic pain. 2. Patient-Oriented Dosing (POD): an alternative dosing of buprenorphine which will be adjusted based on pain levels. The interventions will take place over a period of 12 weeks (3 months). Additionally, participants will complete surveys every 3 months for a period of 1 year (total of 5 survey visits). Participants will receive $50 compensation for each survey visit completed (up to $250 over one year) and can receive up to an additional $100 bonus compensation. There are risks associated with participating in the study, including breach of confidentiality, psychological distress caused by discussing difficult topics, and risks associated with the POD intervention.

Study identification

NCT ID
NCT06367387
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 4
Lead sponsor
Erin Winstanley
Other
Enrollment
273 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 27, 2024
Primary completion
Feb 8, 2026
Completion
Oct 30, 2026
Last update posted
Aug 17, 2026

2024 – 2026

United States locations

U.S. sites
13
U.S. states
4
U.S. cities
9
Facility City State ZIP Site status
Alcohol and Drug Abuse Program (ADAP) - UM Addiction Treatment Center Baltimore Maryland 21223
MATClinics Dundalk Maryland 21222
Wells House Hagerstown Maryland 21740
Central City Concern (CCC) Portland Oregon 97209
Recovery Works Northwest (RWNW) Portland Oregon 97233
OHSU Harm Reduction Bridges to Care (HRBR) Portland Oregon 97239
OHSU Internal Medicine Clinic (IMC) Portland Oregon 97239
UPMC Latterman Family Health Center McKeesport Pennsylvania 15132
UPMC St. Margaret Family Health Center New Kensington Pennsylvania 15068
UPMC Magee-Womens Pregnancy and Women's Recovery Center (PWRC) Pittsburgh Pennsylvania 15213
UPMC Internal Medicine Recovery Engagement Program (IM-REP) Pittsburgh Pennsylvania 15219
WVU Crisis Support & Recovery Center Martinsburg West Virginia 25401
WVU Chestnut Ridge Comprehensive Addiction Treatment Program (COAT) Morgantown West Virginia 26505

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Recently updated Chronic Pain trials

Other public records listing Chronic Pain. Sorted by last update posted; newest first. Not a recommendation.

All Chronic Pain trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06367387, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 17, 2026 · Synced Aug 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06367387 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →